4//SEC Filing
Yaacov-Garbeli Dana 4
Accession 0001178913-23-001531
CIK 0001638097other
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 5:20 PM ET
Size
5.5 KB
Accession
0001178913-23-001531
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Yaacov-Garbeli Dana
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-04-24+190,000→ 190,000 totalExercise: $0.80Exp: 2033-04-24→ Ordinary Shares, par value NIS 0.0000769 per share (190,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period with 25% of the options vesting on April 24, 2024, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
Documents
Issuer
Entera Bio Ltd.
CIK 0001638097
Entity typeother
Related Parties
1- filerCIK 0001909822
Filing Metadata
- Form type
- 4
- Filed
- Apr 24, 8:00 PM ET
- Accepted
- Apr 25, 5:20 PM ET
- Size
- 5.5 KB